These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9740006)

  • 1. Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.
    Quellec P; Gref R; Perrin L; Dellacherie E; Sommer F; Verbavatz JM; Alonso MJ
    J Biomed Mater Res; 1998 Oct; 42(1):45-54. PubMed ID: 9740006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties.
    Quellec P; Gref R; Dellacherie E; Sommer F; Tran MD; Alonso MJ
    J Biomed Mater Res; 1999 Dec; 47(3):388-95. PubMed ID: 10487891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
    Gref R; Lück M; Quellec P; Marchand M; Dellacherie E; Harnisch S; Blunk T; Müller RH
    Colloids Surf B Biointerfaces; 2000 Oct; 18(3-4):301-313. PubMed ID: 10915952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of surface-modified albumin nanospheres.
    Lin W; Garnett MC; Davies MC; Bignotti F; Ferruti P; Davis SS; Illum L
    Biomaterials; 1997 Apr; 18(7):559-65. PubMed ID: 9105596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.
    Stolnik S; Dunn SE; Garnett MC; Davies MC; Coombes AG; Taylor DC; Irving MP; Purkiss SC; Tadros TF; Davis SS
    Pharm Res; 1994 Dec; 11(12):1800-8. PubMed ID: 7899246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.
    Hawley AE; Illum L; Davis SS
    Pharm Res; 1997 May; 14(5):657-61. PubMed ID: 9165539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers.
    Moghimi SM
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):131-9. PubMed ID: 12063176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
    Fresta M; Fontana G; Bucolo C; Cavallaro G; Giammona G; Puglisi G
    J Pharm Sci; 2001 Mar; 90(3):288-97. PubMed ID: 11170022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.
    Mosqueira VC; Legrand P; Gulik A; Bourdon O; Gref R; Labarre D; Barratt G
    Biomaterials; 2001 Nov; 22(22):2967-79. PubMed ID: 11575471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles.
    Rabanel JM; Faivre J; Tehrani SF; Lalloz A; Hildgen P; Banquy X
    ACS Appl Mater Interfaces; 2015 May; 7(19):10374-85. PubMed ID: 25909493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of biodegradable peptide nanospheres with hetero PEG brush surfaces.
    Matsumoto M; Matsusaki M; Akashi M
    Macromol Biosci; 2014 Jan; 14(1):142-50. PubMed ID: 24106226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
    Ruan G; Feng SS
    Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases.
    Li X; Deng X; Huang Z
    Pharm Res; 2001 Jan; 18(1):117-24. PubMed ID: 11336346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.
    Lin W; Coombes AG; Garnett MC; Davies MC; Schacht E; Davis SS; Illum L
    Pharm Res; 1994 Nov; 11(11):1588-92. PubMed ID: 7532861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres.
    Das GS; Rao GHR ; Wilson RF; Chandy T
    J Biomed Mater Res; 2001 Apr; 55(1):96-103. PubMed ID: 11426403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
    Vila A; Gill H; McCallion O; Alonso MJ
    J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.